InteRNA Technologies and Dana-Farber Cancer Institute to collaborate on the role of microRNAs in cancer pathways
“We are very excited about this collaboration with Dr. Hahn, a renowned cancer investigator, and the Dana-Farber, as it allows for functional screens in diverse cell based assays embedded in a lab with extensive knowledge of cancer”, said Roel Schaapveld, Chief Executive Officer of InteRNA Technologies.
“These functional screens hold great promise to help us better understand the roles of miRNAs in cancer and to identify potential treatment targets,” said Dr. Hahn of Dana-Farber Cancer Institute.
Most read news
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.